The Bionics Institute embarked on developing a bionic eye with the Centre for Eye Research Australia (CERA) in 2007. As a member of the nationwide Bionic Vision Australia (BVA) consortium established in 2010, we used our experience in safety and biocompatibility studies to develop a safe and effective electrode array to stimulate the retina.
A clinical trial using our prototype device was successfully completed in 2014 in three patients with retinitis pigmentosa, the most common cause of inherited blindness. This research was supported by the Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA)(2010-2015).
We are now engaged in the clinical trial of the next generation device.
If you would like to register your interest in future eye research trials, please sign up to the Centre for Eye Research Australia Clinical Trials Registry. For any other enquiries, please email email@example.com
If the clinical trials registry is inaccessible, please call number 03 9929 8066 to leave your name and number and a member of the research team will return your call.
In retinitis pigmentosa, the light-sensitive cells of the retina (photoreceptors) degenerate but the retinal neurons that transmit information to the brain remain.
The bionic eye electrically stimulates these surviving retinal cells to provide a sense of vision for people with degenerative eye diseases. The electrode array implanted in the retina delivers electrical stimuli in the form of current pulses that activate nearby cells. This activity is transmitted to the visual areas of the brain (visual cortex) and elicits a perception of a localised flash of light (termed a phosphene).